Consumo de alcool e praticas sexuais de risco: o padrao dos estudantes de enfermagem de uma universidade espanhola

OBJETIVO: determinar la prevalencia del consumo de sustancias tóxicas y de prácticas sexuales sin protección y analizar la relación entre ellas en los estudiantes de Enfermería de la Universidad de Sevilla. MÉTODO: abordaje metodológico cuantitativo con diseño descriptivo y transversal. La población la constituyo el alumnado de Enfermería de 1º de Grado de la Universidad de Sevilla durante el curso académico 2010-2011 (N=510), con muestreo oportunista y consecutivo conformado por el alumnado que acudió a clase el día programado (n=291). RESULTADOS: mostraron alta prevalencia del consumo de alcohol y aumento de la probabilidad de no utilizar medidas de protección en prácticas sexuales cuando se había consumido alcohol. CONCLUSIÓN: estos hallazgos concuerdan con los obtenidos en la misma población en Brasil y ponen de manifiesto la necesidad de fortalecer en el currículo de enfermería, un eje transversal relacionado con la prevención del consumo de sustancias tóxicas, especialmente con el alcohol.OBJETIVO: determinar a prevalência de abuso de substâncias e práticas sexuais inseguras e analisar a relação entre elas em estudantes de enfermagem da Universidade de Sevilha, Espanha. MÉTODO: abordagem metodológica quantitativa, com um delineamento transversal descritivo. A população foi constituída por estudantes do primeiro ano de enfermagem da Universidade de Sevilha, durante o ano lectivo de 2010-2011 (N=510), com amostragem oportunista consecutiva, formada por estudantes que assistiam às aulas na data prevista (n=291). RESULTADOS: alta prevalência de consumo de álcool e aumento da probabilidade de não de não serem utilizadas medidas de proteção durante as práticas sexuais, quando se consumia álcool. CONCLUSÃO: esses resultados são consistentes com aqueles obtidos em uma mesma população no Brasil e se destaca a necessidade de reforçar, no currículo de enfermagem, um eixo transversal relacionado à prevenção de abuso de substâncias, principalmente o álcool.OBJECTIVE: to determine the prevalence of substance abuse and unsafe sexual practices and to analyze the relationship between them, in nursing students at the University of Seville. METHOD: quantitative methodological approach with a descriptive cross-sectional design. The population was composed of first year nursing students in the University of Seville, during the academic year 2010-2011 (N=510), with consecutive opportunistic sampling composed of students who attended class on the scheduled day (n=291). RESULTS: a high prevalence of alcohol consumption, and increased likelihood of not using protective measures during sexual practices when alcohol had been consumed, was present. CONCLUSION: these findings are consistent with those obtained in the same population in Brazil, and highlight the need to strengthen in the nursing curriculum, the transverse axis related to the prevention of substance abuse, especially alcohol

La comunicación web de la RSC- El caso de las empresas cárnicas catalanas

En los últimos años las buenas prácticas de RSC (Responsabilidad Social Corporativa) enfocadas a la sostenibilidad empresarial han ido incrementado su relevancia. La comunicación es una parte intrínseca de la RSC, viabiliza el diálogo con los grupos de interés, pero no siempre es eficiente. El objetivo de este estudio es el de medir y evaluar la gestión de la comunicación web de la RSC que realizan las empresas del sector cárnico catalán, mediante el estudio de las variables significativas del análisis web aplicadas a la información de la RSC disponibles en los websites corporativos

Patient participation in patient safety: systematic review

Objetivo: Identificar as estratégias utilizadas, para participação do paciente na segurança do cuidado de saúde. Métodos: Revisão sistemática, norteada pelas recomendações do modelo PRISMA, nos bancos de dados: Scopus, WOS e Medline. Limitou-se a busca a estudos realizados entre janeiro de 2001 e julho de 2016, redigidos em português, inglês ou espanhol. Foram incluídos estudos observacionais, descritivos, qualitativos e/ou epidemiológicos, que descrevessem a metodologia de elaboração e/ou aplicação de, pelo menos, uma estratégia de inclusão dos pacientes na melhoria da segurança dos cuidados. A qualidade metodológica dos artigos foi avaliada usando a ferramenta Cochrane. Para analisar os resultados se fez uma análise temática. Resultados: Foram encontrados 11593 artigos na busca inicial. Após leitura de títulos, resumos e aplicação de critérios de exclusão, 19 artigos foram selecionados. Nestes se identificam estratégias de mobilização dos pacientes para a segurança dos cuidados, estratégias para promover a participação ativa dos pacientes na segurança dos cuidados e estratégias de solicitação de informação ao paciente sobre a segurança dos cuidados. Conclusões: Há descrita na literatura diversas estratégias que promovem a participação do paciente na segurança dos cuidados, que têm formas e métodos concretos de implementação, bem como objetivos distintos para o seu uso.ABSTRACT - Purpose: Identify strategies used on patients’ participation in patient safety at a hospital and ambulatory environments. Methods: Systematic literature review, following the PRISMA model, using Scopus, WOS, and Medline for data collection. The search was limited to studies carried out between January 2001 and July 2016, written in Portuguese, English or Spanish. Observational, descriptive, qualitative or epidemiologic studies were included if they described a development/appliance methodology using at least one patient safety improvement strategy. Studies’ methodological quality was assessed using Cochrane’s tool. In order to analyze the results, a thematic analysis was performed. Results: On the primary searching, 11593 studies were found. After the title, abstract analysis, and exclusion criteria appliance, 19 studies were ed. On these studies were identified patient safety strategies that promoted patients’ active participation on patient safety and information request strategies. Conclusions: We found a vast panoply of strategies promoting patient participation on patient safety, with concrete implementation methods, as well as distinct purposes for their use.info:eu-repo/semantics/publishedVersio

Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19

Background: Cardiovascular risk factors and usage of cardiovascular medication are prevalent among coronavirus disease 2019 (COVID-19) patients. Little is known about the cardiovascular implications of COVID-19. The goal herein, was to evaluate the prognostic impact of having heart disease (HD) and taking cardiovascular medications in a population diagnosed of COVID-19 who required hospitalization. Also, we studied the development of cardiovascular events during hospitalization. Methods: Consecutive patients with definitive diagnosis of COVID-19 made by a positive real time- -polymerase chain reaction of nasopharyngeal swabs who were admitted to the hospital from March 15 to April 14 were included in a retrospective registry. The association of HD with mortality and with mortality or respiratory failure were the primary and secondary objectives, respectively. Results: A total of 859 patients were included in the present analysis. Cardiovascular risk factors were related to death, particularly diabetes mellitus (hazard ratio in the multivariate analysis: 1.810 [1.159– –2.827], p = 0.009). A total of 113 (13.1%) patients had HD. The presence of HD identified a group of patients with higher mortality (35.4% vs. 18.2%, p < 0.001) but HD was not independently related to prognosis; renin–angiotensin–aldosterone system inhibitors, calcium channel blockers, diuretics and beta-blockers did not worsen prognosis. Statins were independently associated with decreased mortality (0.551 [0.329–0.921], p = 0.023). Cardiovascular events during hospitalization identified a group of patients with poor outcome (mortality 31.8% vs. 19.3% without cardiovascular events, p = 0.007). Conclusions: The presence of HD is related to higher mortality. Cardiovascular medications taken before admission are not harmful, statins being protective. The development of cardiovascular events during the course of the disease is related to poor outcome

Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks : The GR@ACE project

Introduction: Large variability among Alzheimer's disease (AD) cases might impact genetic discoveries and complicate dissection of underlying biological pathways. Methods: Genome Research at Fundacio ACE (GR@ACE) is a genome-wide study of dementia and its clinical endophenotypes, defined based on AD's clinical certainty and vascular burden. We assessed the impact of known AD loci across endophenotypes to generate loci categories. We incorporated gene coexpression data and conducted pathway analysis per category. Finally, to evaluate the effect of heterogeneity in genetic studies, GR@ACE series were meta-analyzed with additional genome-wide association study data sets. Results: We classified known AD loci into three categories, which might reflect the disease clinical heterogeneity. Vascular processes were only detected as a causal mechanism in probable AD. The meta-analysis strategy revealed the ANKRD31-rs4704171 and NDUFAF6-rs10098778 and confirmed SCIMP-rs7225151 and CD33-rs3865444. Discussion: The regulation of vasculature is a prominent causal component of probable AD. GR@ACE meta-analysis revealed novel AD genetic signals, strongly driven by the presence of clinical heterogeneity in the AD series

Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2

The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) had an estimated overall case fatality ratio of 1.38% (pre-vaccination), being 53% higher in males and increasing exponentially with age. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, we found 133 cases (1.42%) with detectable clonal mosaicism for chromosome alterations (mCA) and 226 males (5.08%) with acquired loss of chromosome Y (LOY). Individuals with clonal mosaic events (mCA and/or LOY) showed a 54% increase in the risk of COVID-19 lethality. LOY is associated with transcriptomic biomarkers of immune dysfunction, pro-coagulation activity and cardiovascular risk. Interferon-induced genes involved in the initial immune response to SARS-CoV-2 are also down-regulated in LOY. Thus, mCA and LOY underlie at least part of the sex-biased severity and mortality of COVID-19 in aging patients. Given its potential therapeutic and prognostic relevance, evaluation of clonal mosaicism should be implemented as biomarker of COVID-19 severity in elderly people. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, individuals with clonal mosaic events (clonal mosaicism for chromosome alterations and/or loss of chromosome Y) showed an increased risk of COVID-19 lethality

Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial

Background: Among people with diabetes, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality and progression of their underlying kidney disease. Finerenone is a novel, nonsteroidal, selective mineralocorticoid receptor antagonist that has shown to reduce albuminuria in type 2 diabetes (T2D) patients with chronic kidney disease (CKD) while revealing only a low risk of hyperkalemia. However, the effect of finerenone on CV and renal outcomes has not yet been investigated in long-term trials. Patients and Methods: The Finerenone in Reducing CV Mortality and Morbidity in Diabetic Kidney Disease (FIGARO-DKD) trial aims to assess the efficacy and safety of finerenone compared to placebo at reducing clinically important CV and renal outcomes in T2D patients with CKD. FIGARO-DKD is a randomized, double-blind, placebo-controlled, parallel-group, event-driven trial running in 47 countries with an expected duration of approximately 6 years. FIGARO-DKD randomized 7,437 patients with an estimated glomerular filtration rate >= 25 mL/min/1.73 m(2) and albuminuria (urinary albumin-to-creatinine ratio >= 30 to <= 5,000 mg/g). The study has at least 90% power to detect a 20% reduction in the risk of the primary outcome (overall two-sided significance level alpha = 0.05), the composite of time to first occurrence of CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure. Conclusions: FIGARO-DKD will determine whether an optimally treated cohort of T2D patients with CKD at high risk of CV and renal events will experience cardiorenal benefits with the addition of finerenone to their treatment regimen. Trial Registration: EudraCT number: 2015-000950-39; ClinicalTrials.gov identifier: NCT02545049

Sin / Sense

Sexto desafío por la erradicación de la violencia contra las mujeres del Institut Universitari d’Estudis Feministes i de Gènere «Purificación Escribano» de la Universitat Jaume

Common variants in Alzheimer's disease and risk stratification by polygenic risk scores.

Funder: Funder: Fundación bancaria ‘La Caixa’ Number: LCF/PR/PR16/51110003 Funder: Grifols SA Number: LCF/PR/PR16/51110003 Funder: European Union/EFPIA Innovative Medicines Initiative Joint Number: 115975 Funder: JPco-fuND FP-829-029 Number: 733051061Genetic discoveries of Alzheimer's disease are the drivers of our understanding, and together with polygenetic risk stratification can contribute towards planning of feasible and efficient preventive and curative clinical trials. We first perform a large genetic association study by merging all available case-control datasets and by-proxy study results (discovery n = 409,435 and validation size n = 58,190). Here, we add six variants associated with Alzheimer's disease risk (near APP, CHRNE, PRKD3/NDUFAF7, PLCG2 and two exonic variants in the SHARPIN gene). Assessment of the polygenic risk score and stratifying by APOE reveal a 4 to 5.5 years difference in median age at onset of Alzheimer's disease patients in APOE ɛ4 carriers. Because of this study, the underlying mechanisms of APP can be studied to refine the amyloid cascade and the polygenic risk score provides a tool to select individuals at high risk of Alzheimer's disease